… In conclusion, the main therapeutic advance during the pandemic has been the development
of highly potent neutralizing MAbs for the prevention and treatment of SARS-CoV-2. The …

… demonstrated therapeutic efficacy against SARS-CoV-2, the causative agent of coronavirus
… improve outcomes over single-agent therapies or whether antibody therapies will remain …

… ) and Middle East respiratory syndrome coronavirus (MERS-CoV) was … therapeutic efficacy,
but its safety profile allowed the initiation of drug repurposing research, including SARS-CoV-…

… generation and characterization of a highly efficacious anti-SARS-CoV-2 IgG1 neutralizing
antibody, SC31. Significantly, we show that the therapeutic efficacy of SC31 is not solely due …

… importance, Ab08 shows therapeutic efficacy in SARS-CoV-2-… Together, our work identifies
a nAb with therapeutic potential … demonstrate therapeutic efficacy of Ab08 in SARS-CoV-2-…

… SARS-CoV-2 remains a global threat to human health … binding domain (RBD) of the
SARS-CoV-2 spike protein. Crystal … route showed potent therapeutic efficacy in the Syrian hamster …

… efficacy against SARS and MERS, have been used in patients with COVID-19. This systematic
review aims to summarize evidence on the efficacy … in studies on SARS-CoV and MERS.; …

… will evaluate the efficacy and safety of CERC002 in patients with severe SARS-CoV-2 for
28 … in hospitalized patients with mild to moderate SARS-CoV-2-associated pneumonia (ARDS) …

… with viral diseases, especially SARS CoV-2, the impacts of cannabinoids in SARS-CoV-2
infection, as well as preclinical and clinical evidence of cannabinoid efficacy, and ends with the …

… , a novel SARS-CoV-2 coronavirus emerged, … efficacy against similar pathogens. Chloroquine,
remdesivir, lopinavir/ritonavir or ribavirin have all been successful in inhibiting SARS-CoV-…